HYGEIA Hospital
ΛΗΤΩ Μαιευτικό, Γυναικολογικό & Χειρουργικό Κέντρο
Creta InterClinic – Ιδιωτική Κλινική | Διαγνωστικό Κέντρο
AlfaLab | Kέντρο Μοριακής Βιολογίας & Κυτταρογενετικής
Digital Clinic
Business Care
Y-Logimed Α.Ε.


27 November 2017

During its meeting on 27/11/2017, the Board of Directors of DTCA HYGEIA SA (“HYGEIA”):

  1. A) Was briefed on the submitted public proposal for acquisition of 30% of the Company’s shares.
  2. B) Decided to appoint an independent financial advisor, in accordance with Article 15(2) of Law 3461/2006, who shall draw up a valuation report on the fair value of the Company’s shares. They shall then inform the investing public about the content of the report and their opinion on the public proposal.
  3. C) Was briefed on the announcement issued on 24/11/2017 by Marfin Investment Group (MIG) – HYGEIA’s majority shareholder, which has a 70.38% stake in the Company and exclusive control of HYGEIA – whereby MIG is not willing to proceed with the sale of any shares. The Board Members also announced that they are not willing to proceed with the sale of any shares.

In all events, the HYGEIA Board of Directors urges the investing public to study the HYGEIA financial figures, with the help of special advisors if necessary, so as to form their own opinions as to the content of the submitted public proposal.